Hepatitis C in hemodialysis patients

Table 2 Hepatitis C virus-associated mortality in hemodialysis patients: National surveys

National survey	Ref.	No. of HD patients	Outcome	Relative risk
Australia New Zealand Dialysis and Transplant Registry	Scott et al[62]	23046 (10-yr follow up)	Independent and significant association between a HCV(+) and all-cause mortality	HR = 1.25 (95%CI: 1.07-1.46, P = 0.004)
National or regional dialysis registries of 10 Asia-Pacific countries/areas (Australia, New Zealand, Japan, China, Taiwan, Korea, Thailand, Hong-Kong, Malaysia, India)	Johnson et al[63]	173788	Data available for Australia, New Zealand and Japan	HR = 1.25 (95%CI: 1.07-1.46, P = 0.004)
Dialysis Outcomes and Practice Patterns Study (DOPPS) from the United States (in three continents: Europe, Japan, United States)	Goodkin et al[64]	206134	a HCV(+) is an independent predictor of all-cause mortality	RR = 1.17 (P < 0.0159)
The Japanese cohort	Japanese Society of Dialysis[65]	76201	a HCV(+) is an independent predictor of all-cause mortality	RR = 1.37 (95%CI: 1.15-1.62, P = 0.003)

HD: Hemodialysis; HCV: Hepatitis C virus.